Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
13F holders, Q3 2024
Institutional positions in Genmab A/S as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 224
- +6 vs. Q2 2024
- Shares held
- 52.3M
- +8.66M (+19.8%) vs. Q2 2024
- Total value
- $1.27B
- +$173.2M (+15.8%) vs. Q2 2024
- New holders
- 30
- 98 more added
- Sold out
- 24
- 65 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GMAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 291 | $2.81B |
| Q1 2026 | 275 | $2.23B |
| Q4 2025 | 293 | $2.26B |
| Q3 2025 | 253 | $1.89B |
| Q2 2025 | 218 | $1.32B |
| Q1 2025 | 220 | $1.27B |
| Q4 2024 | 230 | $1.27B |
| Q3 2024 | 224 | $1.27B |
| Q2 2024 | 220 | $1.23B |
| Q1 2024 | 227 | $1.43B |
| Q4 2023 | 226 | $1.48B |
| Q3 2023 | 234 | $1.67B |
| Q2 2023 | 214 | $1.59B |
| Q1 2023 | 217 | $1.62B |
| Q4 2022 | 238 | $1.94B |
| Q3 2022 | 194 | $1.43B |
| Q2 2022 | 181 | $1.15B |
| Q1 2022 | 204 | $1.41B |
| Q4 2021 | 212 | $1.58B |
| Q3 2021 | 213 | $1.89B |
| Q2 2021 | 213 | $1.89B |
| Q1 2021 | 211 | $1.37B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Genmab A/S; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 428,053 | $10.4M | 0.01% | −220,326−34.0% | Reduced |
| Northern Trust Corp | 504,523 | $12.3M | 0.00% | −14,861−2.9% | Reduced |
| Voloridge Investment Management, LLC | 548,424 | $13.4M | 0.05% | +20,195+3.8% | Added |
| Millennium Management LLC | 564,832 | $13.8M | 0.01% | +183,837+48.3% | Added |
| DDD Partners, LLC | 583,113 | $14.2M | 1.54% | +230,544+65.4% | Added |
| Two Sigma Advisers, LP | 615,100 | $15.0M | 0.04% | +280,900+84.1% | Added |
| Wells Fargo & Company | 700,404 | $17.1M | 0.00% | −23,101−3.2% | Reduced |
| Two Sigma Investments, LP | 767,909 | $18.7M | 0.04% | +58,328+8.2% | Added |
| Royal Bank of Canada | 797,813 | $19.4M | 0.00% | +5,059+0.6% | Added |
| Goldman Sachs Group Inc | 825,146 | $20.1M | 0.00% | −52,706−6.0% | Reduced |
| Envestnet Asset Management Inc | 1,043,560 | $25.4M | 0.01% | +47,893+4.8% | Added |
| Bank of America Corp | 1,054,446 | $25.7M | 0.00% | −42,825−3.9% | Reduced |
| Citadel Advisors LLC | 1,299,856 | $31.7M | 0.03% | +28,968+2.3% | Added |
| First Trust Advisors LP | 1,393,047 | $34.0M | 0.03% | +184,074+15.2% | Added |
| Morgan Stanley | 1,640,390 | $40.0M | 0.00% | +611,013+59.4% | Added |
| Orbis Allan Gray Ltd | 1,676,793 | $40.9M | 0.22% | +1,676,793 | New |
| Renaissance Technologies LLC | 1,786,428 | $43.6M | 0.07% | +323,969+22.2% | Added |
| Wellington Management Group LLP | 2,306,250 | $56.2M | 0.01% | −6700.0% | Reduced |
| Harding Loevner LP | 3,066,942 | $74.7M | 0.43% | +299,137+10.8% | Added |
| Capital International Investors | 4,421,617 | $107.6M | 0.02% | +193,652+4.6% | Added |
| BlackRock, Inc. | 4,616,963 | $112.6M | 0.00% | +4,616,963 | New |
| Alliancebernstein L.P. | 15,136,152 | $369.0M | 0.12% | −101,687−0.7% | Reduced |
| Groupama Asset Managment | 11,253 | – | – | +1,225+12.2% | Added |
| Mediolanum International Funds Ltd | 28,661 | – | – | +28,661 | New |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −278,541−100.0% | Sold out |
| Royal London Asset Management Ltd | 0 | $0 | 0.00% | −49,849−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −28,480−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −27,600−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −18,184−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,368−100.0% | Sold out |
| Greenleaf Trust | 0 | $0 | 0.00% | −13,230−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,351−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −10,053−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −8,698−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −8,189−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −5,138−100.0% | Sold out |
| SYSTM Wealth Solutions LLC | 0 | $0 | 0.00% | −1,447−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −234−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −167−100.0% | Sold out |
| RFP Financial Group LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |
| Front Row Advisors LLC | 0 | $0 | 0.00% | −154−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Opal Wealth Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Lynx Investment Advisory | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Zions Bancorporation, N.A. | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Benjamin F. Edwards & Company, Inc. | – | – | – | – | Not filed |